1. Home
  2. NBY vs SNGX Comparison

NBY vs SNGX Comparison

Compare NBY & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBY
  • SNGX
  • Stock Information
  • Founded
  • NBY 2000
  • SNGX 1987
  • Country
  • NBY United States
  • SNGX United States
  • Employees
  • NBY N/A
  • SNGX N/A
  • Industry
  • NBY
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NBY
  • SNGX Health Care
  • Exchange
  • NBY Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • NBY 3.8M
  • SNGX 4.3M
  • IPO Year
  • NBY 2007
  • SNGX 1987
  • Fundamental
  • Price
  • NBY $0.61
  • SNGX $3.70
  • Analyst Decision
  • NBY Strong Buy
  • SNGX Strong Buy
  • Analyst Count
  • NBY 1
  • SNGX 1
  • Target Price
  • NBY $0.85
  • SNGX $6.00
  • AVG Volume (30 Days)
  • NBY 43.7K
  • SNGX 31.5M
  • Earning Date
  • NBY 08-14-2025
  • SNGX 08-14-2025
  • Dividend Yield
  • NBY N/A
  • SNGX N/A
  • EPS Growth
  • NBY N/A
  • SNGX N/A
  • EPS
  • NBY 0.41
  • SNGX N/A
  • Revenue
  • NBY $9,781,000.00
  • SNGX N/A
  • Revenue This Year
  • NBY $23.91
  • SNGX N/A
  • Revenue Next Year
  • NBY $32.05
  • SNGX N/A
  • P/E Ratio
  • NBY $1.56
  • SNGX N/A
  • Revenue Growth
  • NBY 113.47
  • SNGX N/A
  • 52 Week Low
  • NBY $0.44
  • SNGX $1.09
  • 52 Week High
  • NBY $1.01
  • SNGX $6.23
  • Technical
  • Relative Strength Index (RSI)
  • NBY 48.11
  • SNGX 60.84
  • Support Level
  • NBY $0.54
  • SNGX $2.32
  • Resistance Level
  • NBY $0.65
  • SNGX $6.23
  • Average True Range (ATR)
  • NBY 0.04
  • SNGX 0.92
  • MACD
  • NBY 0.00
  • SNGX 0.13
  • Stochastic Oscillator
  • NBY 41.19
  • SNGX 44.64

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: